EndoGI Medical

Company Overview

Snapshot

Founded in May 2017 by Omri Nechmadi Naveh, Ronny Barak, and Elad Einav, EndoGI Medical operates with 1–10 employees. The company has secured $54.68K in total capital across 3 funding rounds from 2 investors. In July 2020, EndoGI Medical received FDA approval for its technology, enabling the simultaneous insertion of multiple stents into bile ducts.

Business overview

EndoGI Medical is a medical device company focused on developing advanced solutions for gastrointestinal conditions. The company's core technology is a multiple stent placement delivery system designed to treat biliary and pancreatic duct stenosis and strictures, which can be caused by cancer, injury, inflammation, cholangitis, or gallstones. This system facilitates the insertion and placement of two or more plastic stents with a single passage, maintaining guidewire access at the targeted anatomical site. EndoGI Medical serves the healthcare industry, specifically targeting hospitals, doctors, and clinics with its gastroenterology-focused medical devices.

Strategic signal

In July 2020, EndoGI Medical received FDA approval for its innovative technology, which allows for the simultaneous insertion of two stents into the bile ducts connected to the pancreas. This approval is a significant validation of the company's technology, as it addresses a critical need to reduce patient exposure to infections and other life-threatening situations associated with repetitive singular stent insertions. This milestone signals strong regulatory acceptance and opens the door for the company to market its technology for clinical use in the United States, positioning it for potential growth in the medical device market.

Company Intelligence Q&A

What is EndoGI Medical's primary focus?

EndoGI Medical is a medical device company developing a multiple stent placement delivery system for the treatment of biliary and pancreatic duct stenosis and strictures.

When was EndoGI Medical founded and by whom?

EndoGI Medical was founded in May 2017 by Omri Nechmadi Naveh, Ronny Barak, and Elad Einav.

What significant regulatory approval did EndoGI Medical receive?

In July 2020, EndoGI Medical received FDA approval for its technology, which enables the insertion of two stents simultaneously into the bile ducts connected to the pancreas.

Which investors have participated in EndoGI Medical's funding rounds?

In August 2022, EndoGI Medical received funding from NGT HealthCare II. In April 2019, the company also secured funding from NGT3.